Annual Accounts Payable
$18.99 M
+$2.56 M+15.59%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual accounts payable is $18.99 million, with the most recent change of +$2.56 million (+15.59%) on December 31, 2022.
- During the last 3 years, EGRX annual accounts payable has risen by +$13.53 million (+247.73%).
- EGRX annual accounts payable is now at all-time high.
Performance
EGRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$15.84 M
-$1.26 M-7.39%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly accounts payable is $15.84 million, with the most recent change of -$1.26 million (-7.39%) on June 30, 2023.
- Over the past year, EGRX quarterly accounts payable has dropped by -$4.13 million (-20.67%).
- EGRX quarterly accounts payable is now -20.67% below its all-time high of $19.97 million, reached on June 30, 2022.
Performance
EGRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
EGRX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.6% | -20.7% |
| 3 y3 years | +247.7% | +15.6% |
| 5 y5 years | +58.5% | -13.3% |
EGRX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +15.6% | -20.7% | +19.9% |
| 5 y | 5-year | at high | +247.7% | -20.7% | +190.1% |
| alltime | all time | at high | +1493.4% | -20.7% | +1229.1% |
Eagle Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $15.84 M(-7.4%) |
| Mar 2023 | - | $17.11 M(-9.9%) |
| Dec 2022 | $18.99 M(+15.6%) | $18.99 M(+43.7%) |
| Sep 2022 | - | $13.21 M(-33.8%) |
| Jun 2022 | - | $19.97 M(+37.6%) |
| Mar 2022 | - | $14.51 M(-11.7%) |
| Dec 2021 | $16.43 M(+162.1%) | $16.43 M(+29.2%) |
| Sep 2021 | - | $12.72 M(+14.2%) |
| Jun 2021 | - | $11.14 M(-11.3%) |
| Mar 2021 | - | $12.56 M(+100.4%) |
| Dec 2020 | $6.27 M(+14.8%) | $6.27 M(-52.0%) |
| Sep 2020 | - | $13.07 M(-4.7%) |
| Jun 2020 | - | $13.71 M(+40.5%) |
| Mar 2020 | - | $9.76 M(+78.6%) |
| Dec 2019 | $5.46 M(-44.9%) | $5.46 M(-51.4%) |
| Sep 2019 | - | $11.23 M(-35.1%) |
| Jun 2019 | - | $17.30 M(+3.0%) |
| Mar 2019 | - | $16.79 M(+69.3%) |
| Dec 2018 | $9.92 M | $9.92 M(+31.5%) |
| Sep 2018 | - | $7.54 M(-58.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $18.27 M(+95.3%) |
| Mar 2018 | - | $9.35 M(-21.9%) |
| Dec 2017 | $11.98 M(-18.6%) | $11.98 M(+34.6%) |
| Sep 2017 | - | $8.90 M(-26.7%) |
| Jun 2017 | - | $12.15 M(-36.2%) |
| Mar 2017 | - | $19.03 M(+29.3%) |
| Dec 2016 | $14.72 M(+281.5%) | $14.72 M(+12.3%) |
| Sep 2016 | - | $13.10 M(+14.6%) |
| Jun 2016 | - | $11.43 M(+11.0%) |
| Mar 2016 | - | $10.29 M(+166.9%) |
| Dec 2015 | $3.86 M(-5.0%) | $3.86 M(-72.7%) |
| Sep 2015 | - | $14.15 M(+195.8%) |
| Jun 2015 | - | $4.78 M(-12.0%) |
| Mar 2015 | - | $5.43 M(+55.2%) |
| Dec 2014 | - | $3.50 M(-13.7%) |
| Sep 2014 | $4.06 M(+240.5%) | $4.06 M(+61.0%) |
| Jun 2014 | - | $2.52 M(+2.5%) |
| Mar 2014 | - | $2.46 M(+4.8%) |
| Dec 2013 | - | $2.35 M(+96.9%) |
| Sep 2013 | $1.19 M(-17.4%) | $1.19 M |
| Sep 2012 | $1.44 M | - |
FAQ
- What is Eagle Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual accounts payable year-on-year change?
- What is Eagle Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly accounts payable year-on-year change?
What is Eagle Pharmaceuticals annual accounts payable?
The current annual accounts payable of EGRX is $18.99 M
What is the all time high annual accounts payable for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual accounts payable is $18.99 M
What is Eagle Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, EGRX annual accounts payable has changed by +$2.56 M (+15.59%)
What is Eagle Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of EGRX is $15.84 M
What is the all time high quarterly accounts payable for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly accounts payable is $19.97 M
What is Eagle Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, EGRX quarterly accounts payable has changed by -$4.13 M (-20.67%)